• About us
• Contact

Advertisement

Organisation › Details

Biosynth AG

Biosynth is a supplier of critical materials, securing life science supply chains with global research, manufacturing, and distribution facilities. Supplying the pharmaceutical and diagnostic sectors; where Chemistry meets Biology, Products meet Services and Innovation meets Quality, Biosynth is at the Edge of Innovation. With an unrivaled research product portfolio of over a million products and end-to-end manufacturing services, Biosynth’s expertise and capability runs across Complex Chemicals, Peptides, and Key Biologics, all from one trusted partner. Headquartered in Staad, Switzerland, Biosynth is owned amongst others by KKR, Ampersand Capital Partners and management. *

 

	Start	2007-11-07 existent
	Group	Biosynth (since 9/22) (Group)
	Industry	reagents (bio/biochemical)
	Person	Spitz, Urs (Biosynth 201905 CEO)
	Region	Switzerland_oo
	Country	Switzerland
	Street	4 Rietlistr.
	City	9422 Staad
	Tel	+41-71-858-2020
		Address record changed: 2022-09-06
Basic data	Employees	n. a.
		* Document for »About Section«: Biosynth AG. (7/11/23). "Press Release: Biosynth Expands Capabilities with Acquisition of Celares, Experts in Bioconjugation and Specialty Polymers". Staad.
		Record changed: 2023-09-26

Advertisement

More documents for Biosynth (since 9/22) (Group)

• [1] Biosynth AG. (9/25/23). "Press Release: Biosynth Extends its Offering to Multi-Kilogram GMP Peptide Synthesis through the Acquisition of Pepceuticals". Staad....
• [2] Biosynth AG. (7/11/23). "Press Release: Biosynth Expands Capabilities with Acquisition of Celares, Experts in Bioconjugation and Specialty Polymers". Staad....
• [3] Biosynth AG. (5/9/23). "Press Release: Biosynth Further Strengthens Peptide Business with Acquisition of Cambridge Research Biochemicals". Staad....
• [4] Biosynth AG. (1/19/23). "Press Release: Biosynth Hit 1M Products in Catalog. The Widest Catalog to Be the Leading Global Supplier"....
• [5] Biosynth AG. (9/7/22). "Press Release: Biosynth Carbosynth, Vivitide and Pepscan Rebrand to Biosynth". Staad....
• [6] Biosynth Carbosynth. (8/2/22). "Press Release: Biosynth Carbosynth to Offer Enzyme Development Following Acquisition of Eucodis Bioscience". Staad....
• [7] Biosynth Carbosynth. (6/30/22). "Press Release: Biosynth Carbosynth Expands Peptide Offering with Acquisition of Pepscan". Staad....
• [8] Biosynth Carbosynth. (5/25/22). "Press Release: Biosynth Carbosynth Further Expands Life Sciences Platform with Acquisition of Aalto Bio Reagents". Staad....
• [9] Bicycle Therapeutics plc. (11/20/20). "Press Release: Bicycle Therapeutics Announces Settlement of Patent Dispute with Pepscan Systems B.V.". Cambridge & Boston, MA....
• [10] Biosynth Carbosynth. (11/3/20). "Press Release: Biosynth Carbosynth Expands Its Enzyme Offerings with Products for Industrial Applications"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.